CHI3L1 and acute myeloid leukemia: Additionally, utilising primary xenograft models of AML, they demonstrated that primary AML blasts that successfully engrafted into non-obese diabetic/severe combined immunodeficiency (NOD-SCID) mice upregulated YM-1 (CHI3L1) on Ly6C+ BM monocytes.